Use of tacrolimus in the treatment of autoimmune hepatitis: A single centre experience

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 3, 2011, Pages 405-407

  Tannous, M M ^a   Cheng, J ^a   Muniyappa, K ^a   Farooq, I ^a   Bharara, A ^a   Kappus, M ^a   Luketic, V ^a   Stravtiz, R T ^a   Fuchs, M ^a   Puri, P ^a   Sanyal, A ^a   Sterling, R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; TACROLIMUS;

ADULT; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; FEMALE; HAIR LOSS; HEMOLYTIC UREMIC SYNDROME; HUMAN; LETTER; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UNITED STATES;

FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREGNANCY;

EID: 79959994108     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04749.x     Document Type: Letter

References (8)

1. Yeoman AD, Longhi MS, Heneghan MA,. Review article: the modern management of autoimmune hepatitis. Aliment Pharmacol Ther 2010; 31: 771-87.
2. Czaja AJ, Freese D,. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97. (Pubitemid 34810370)
3. Zeniya M, Toda G,. Autoimmune liver disease: current therapy. Intern Med 2000; 39: 346-7. (Pubitemid 30313996)
4. Van Thiel DH, Wright H, Carroll P, et al. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995; 90: 771-6.
5. Heneghan MA, Rizzi P, McFarlane IG, Portmann B, Harrison PM,. Low dose tacrolimus as treatment of severeautoimmune hepatitis: potential role in remission induction. Gut 1999; 44 (Suppl. 1): A61.
6. Larsen FS, Vainer B, Eefsen M, Bjerring PN, Hansen BA,. Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis. World J Gastroenterol 2007; 13: 3232-6. (Pubitemid 47064587)
7. Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC,. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol 2004; 38: 805-9. (Pubitemid 39274185)
8. Chatur N, Ramji A, Bain VG, et al. Transplant immunosuppressive agents in non-transplant chronic autoimmunehepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Liver Int 2005; 25: 723-7. (Pubitemid 41038652)